Nasdaq:US$18.78 (-0.58) | HKEX:HK$30.20 (+0.30) | AIM:£3.00 (+0.03)
News & Presentations
Previous Article   |   Next Article
Presentations | 12 Oct 2023

Preclinical characterization of HMPL-415, a second-generation SHP2 inhibitor